Latest Usual interstitial pneumonia Stories
CPF and PFF Commit to ATS to Fund Grants CULVER CITY, Calif., Feb.
Esbriet (Pirfenidone) Passes Hurdle, Way Clear for EU Approval CULVER CITY, Calif., Dec.
Pulmonary Fibrosis Claims as Many Lives Each Year as Breast Cancer, Yet Virtually Unknown PEORIA, Ariz., Dec. 8, 2010 /PRNewswire-USNewswire/ -- Elliot Walsey is on a mission to save others who suffer from the disease that will likely kill him.
Inaugural IPF Summit: From Bench to Bedside to be held in Chicago, IL December 1-3, 2011 in Partnership with National Jewish Health and France Foundation CHICAGO, Oct.
CULVER CITY, Calif., Oct. 4 /PRNewswire-USNewswire/ -- The Coalition for Pulmonary Fibrosis (CPF) has announced its annual awards honoring three critical areas of leadership that impact the work of the Pulmonary Fibrosis (PF) community.
CHICAGO, Aug. 4 /PRNewswire-USNewswire/ -- The Pulmonary Fibrosis Foundation (PFF) today announced that the Pulmonary Fibrosis Research Enhancement Act (PFREA) was introduced in the United States Senate.
Decision Marks Delay in Potential First Treatment for Deadly Disease SAN JOSE, Calif., May 4 /PRNewswire-USNewswire/ -- The Coalition for Pulmonary Fibrosis (CPF), representing tens of thousands of patients, is responding to the news that the FDA chose to ask for further study of Pirfenidone, which will delay potential approval of the first drug in the treatment of Pulmonary Fibrosis (PF), a lethal lung disease that is irreversible, progressive and deadly in an average of three years.
SAN JOSE, Calif., April 9 /PRNewswire-USNewswire/ -- The Coalition for Pulmonary Fibrosis, The Pulmonary Fibrosis Foundation and the Pulmonary Fibrosis Association of Texas today announced the launch of a special, grassroots campaign to build increased national awareness of Pulmonary Fibrosis (PF).
PF Patients Plead with FDA Advisory Panel to Hear Their Voices, Understand Their Plight SILVER SPRING, Md., March 10 /PRNewswire-USNewswire/ -- The Coalition for Pulmonary Fibrosis (CPF) and the Pulmonary Fibrosis Foundation (PFF) are applauding the efforts of Pulmonary Fibrosis (PF) patients and family members for their work to convey to the FDA and an FDA Advisory Committee the sense of urgency and desperation regarding the disease and the lack of treatment options.
His Longevity with the Deadly Disease Inspires Thousands of Dying Patients SAN JOSE, Calif., Sept.
- an ornament or knob in the shape of a flower